| Jangka wektu | Prediksi rega | kepungkur | Sajarah | Wawasan |
|---|---|---|---|---|
| sesuk | $1.17 ▲ +1.41% | wingi | $1.14 ▼ -0.59% | Sesuk Bio Xcel Therapeutics Inc. Common Stock (BTAI) persiyapan wis anchored kanggo $1.15 lan target $1.17 (+1.41%). Waca sing cedhak yaiku munggah; nonton $1.18 / $1.12 amarga volatilitas sing diwujudake saben dina babagan 7.29%. |
Sesuk Bio Xcel Therapeutics Inc. Common Stock (BTAI) persiyapan wis anchored kanggo $1.15 lan target $1.17 (+1.41%). Waca sing cedhak yaiku munggah; nonton $1.18 / $1.12 amarga volatilitas sing diwujudake saben dina babagan 7.29%. | ||||
| Minggu | $1.20 ▲ +4.40% | Minggu kepungkur | $1.13 ▼ -1.85% | Model 7 dina Bio Xcel Therapeutics Inc. Common Stock pindhah saka $1.13 menyang $1.20 (+4.40%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $1.18 / $1.12 prakara luwih saka siji obah. |
Model 7 dina Bio Xcel Therapeutics Inc. Common Stock pindhah saka $1.13 menyang $1.20 (+4.40%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $1.18 / $1.12 prakara luwih saka siji obah. | ||||
| wulan | $1.26 ▲ +9.37% | Wulan kepungkur | $1.10 ▼ -3.94% | Target 1 wulan Bio Xcel Therapeutics Inc. Common Stock yaiku $1.26 (+9.37%), dibandhingake karo referensi langsung ing cedhak $1.15. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. |
Target 1 wulan Bio Xcel Therapeutics Inc. Common Stock yaiku $1.26 (+9.37%), dibandhingake karo referensi langsung ing cedhak $1.15. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. | ||||
| taun | $1.34 ▲ +16.82% | Taun kepungkur | $1.07 ▼ -7.07% | Skenario 1 taun Bio Xcel Therapeutics Inc. Common Stock nuduhake $1.34 (+16.82%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. |
Skenario 1 taun Bio Xcel Therapeutics Inc. Common Stock nuduhake $1.34 (+16.82%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. | ||||
| 5 Taun | $1.54 ▲ +34.29% | 5 Taun kepungkur | $0.9844 ▼ -14.40% | Tampilan 5 taun Bio Xcel Therapeutics Inc. Common Stock yaiku $1.54 (+34.29%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. |
Tampilan 5 taun Bio Xcel Therapeutics Inc. Common Stock yaiku $1.54 (+34.29%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. | ||||
| Indikator | Nilai | Sinyal |
|---|---|---|
| regane | $1.15 | agêng |
| Ganti saben dina | -4.17% | Ngisor |
| Volatilitas Kab | 20.0% | agêng |
| kapercayan | 66% | Ndhuwur |
| Sumber Data | nasdaq-screener | agêng |
| saiki | $1.15 | Ganti saben dina | -4.17% |
| Pasar Kab | $31.14M | Sumber | nasdaq-screener |
Gagasan sing gegandhengan kanggo navigasi internal, diklompokaké miturut persiyapan sisih ndhuwur sing luwih kuwat lan kurang lemah ing pasar sing padha.